Company Filing History:
1 out of 55 
1 out of 17 
1 out of 101 
Years Active: 2011-2015
Title: Innovations by Marcelis Van Der Stelt
Introduction
Marcelis Van Der Stelt is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, holding three patents that focus on innovative compounds for medical applications. His work is particularly relevant in the treatment of various health conditions, showcasing his commitment to advancing medical science.
Latest Patents
One of his latest patents involves N-piperidin-4-yl derivatives. This invention relates to a N-piperidin-4-yl derivative that has the general Formula I or a pharmaceutically acceptable salt thereof. It includes pharmaceutical compositions comprising these derivatives and their use in treating and preventing endometriosis, pre-menopausal and peri-menopausal hormone-dependent breast cancer, contraception, and uterine fibroids or other menstrual-related disorders. Another significant patent is for 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives. This invention pertains to a derivative having the general Formula I, which is utilized in pharmaceutical compositions for treating various types of pain, including peri-operative pain, chronic pain, neuropathic pain, cancer pain, and pain associated with multiple sclerosis.
Career Highlights
Marcelis has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme B.V. and MSD Oss B.V. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.
Collaborations
Some of his notable coworkers include Joseph Maria Gerardus Barbara Cals and Ines Huisman. Their collaboration has likely fostered a productive environment for innovation and research.
Conclusion
Marcelis Van Der Stelt's contributions to the field of pharmaceuticals through his patents demonstrate his dedication to improving healthcare solutions. His innovative work continues to impact the treatment of significant medical conditions.